Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.89
-0.03 (-1.56%)
At close: May 14, 2025, 3:59 PM
1.91
1.06%
After-hours: May 14, 2025, 07:59 PM EDT
Inovio Pharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segments Revenue | 217.76K |
| Reportable Segments Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.6M | 8.61M | 10.21M | 9.81M | 10.07M | 9.93M | 13.52M | 13.89M | 13.95M | 11.82M | 48.46M | 15.95M | 14.05M | 13.16M | 12.67M | 13.88M | 8.62M | 10.11M | 11.07M | 7.45M | 8.7M | 5.68M | 5.85M | 6.98M | 5.64M | 6.79M | 7.19M | 9.7M | 8.03M | 6.32M | 6.17M | 7.77M | 6.97M | 5.76M | 5.8M | 5.37M | 4.86M | 4.38M | 4.72M | 4.11M |
| Selling, General, and Administrative Revenue Growth | -11.76% | -15.61% | +4.03% | -2.55% | +1.44% | -26.61% | -2.65% | -0.43% | +17.99% | -75.60% | +203.74% | +13.56% | +6.78% | +3.87% | -8.75% | +61.08% | -14.77% | -8.68% | +48.64% | -14.35% | +53.07% | -2.88% | -16.13% | +23.76% | -17.01% | -5.53% | -25.87% | +20.71% | +27.12% | +2.44% | -20.58% | +11.51% | +21.02% | -0.76% | +7.97% | +10.53% | +11.02% | -7.22% | +14.86% | n/a |
| Research and Development Revenue | 12.89M | 18.73M | 23.09M | 20.91M | 17.25M | 15.5M | 23.74M | 30.18M | 42.12M | 33.09M | 56.46M | 55.98M | 92.3M | 47.09M | 70.81M | 39.04M | 26.3M | 26.46M | 22.38M | 19.11M | 22M | 19.14M | 22.49M | 24.39M | 26.37M | 21.85M | 22.46M | 24.58M | 24.64M | 25.51M | 23.88M | 24.54M | 23.91M | 26.98M | 19.63M | 18.19M | 15.6M | 16.08M | 16.69M | 9.43M |
| Research and Development Revenue Growth | -31.22% | -18.87% | +10.41% | +21.22% | +11.29% | -34.71% | -21.32% | -28.36% | +27.30% | -41.40% | +0.87% | -39.35% | +96.01% | -33.50% | +81.35% | +48.44% | -0.58% | +18.23% | +17.09% | -13.15% | +14.98% | -14.89% | -7.80% | -7.49% | +20.66% | -2.72% | -8.61% | -0.26% | -3.41% | +6.83% | -2.70% | +2.64% | -11.37% | +37.44% | +7.93% | +16.58% | -2.94% | -3.68% | +77.04% | n/a |